Erica Maria Pimenta, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Interferon Regulatory Factors | 4 | 2017 | 280 | 1.180 |
Why?
|
| B-Lymphocytes | 1 | 2014 | 4918 | 0.200 |
Why?
|
| Breast Neoplasms | 3 | 2015 | 20059 | 0.180 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 6371 | 0.150 |
Why?
|
| T-Lymphocytes | 1 | 2014 | 10379 | 0.150 |
Why?
|
| Chemokine CXCL13 | 1 | 2014 | 54 | 0.140 |
Why?
|
| Receptors, CXCR5 | 1 | 2014 | 79 | 0.140 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2015 | 452 | 0.120 |
Why?
|
| Culture Media, Conditioned | 1 | 2014 | 550 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2021 | 8674 | 0.120 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2015 | 510 | 0.110 |
Why?
|
| Cell Movement | 2 | 2015 | 5468 | 0.110 |
Why?
|
| Transgenes | 1 | 2014 | 1020 | 0.100 |
Why?
|
| Conserved Sequence | 1 | 2015 | 1247 | 0.100 |
Why?
|
| Cytoplasm | 1 | 2015 | 1636 | 0.100 |
Why?
|
| Cytoskeletal Proteins | 1 | 2015 | 1415 | 0.090 |
Why?
|
| Tumor Microenvironment | 2 | 2021 | 3071 | 0.080 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 4250 | 0.080 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2021 | 2964 | 0.070 |
Why?
|
| Kidney Neoplasms | 1 | 2021 | 4042 | 0.070 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2011 | 916 | 0.060 |
Why?
|
| Gene Expression | 2 | 2015 | 8010 | 0.060 |
Why?
|
| Cell Line, Tumor | 3 | 2017 | 16943 | 0.060 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2011 | 1102 | 0.060 |
Why?
|
| Transcription, Genetic | 2 | 2015 | 7947 | 0.060 |
Why?
|
| Epithelial Cells | 1 | 2015 | 3687 | 0.060 |
Why?
|
| Protein Binding | 1 | 2015 | 9661 | 0.060 |
Why?
|
| Peptide Fragments | 1 | 2015 | 5155 | 0.050 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1055 | 0.030 |
Why?
|
| Prognosis | 1 | 2015 | 29168 | 0.030 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2011 | 72 | 0.030 |
Why?
|
| Hepatocytes | 1 | 2017 | 1249 | 0.020 |
Why?
|
| Hepacivirus | 1 | 2017 | 1321 | 0.020 |
Why?
|
| Chemokine CXCL12 | 1 | 2011 | 470 | 0.020 |
Why?
|
| Hepatitis C, Chronic | 1 | 2017 | 1003 | 0.020 |
Why?
|
| Virus Replication | 1 | 2017 | 2544 | 0.020 |
Why?
|
| Radiation Tolerance | 1 | 2011 | 510 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2011 | 624 | 0.020 |
Why?
|
| Hepatitis C | 1 | 2017 | 1517 | 0.020 |
Why?
|
| Liver Cirrhosis | 1 | 2017 | 1748 | 0.020 |
Why?
|
| Female | 3 | 2015 | 377334 | 0.020 |
Why?
|
| Receptors, CXCR4 | 1 | 2011 | 735 | 0.020 |
Why?
|
| Humans | 5 | 2021 | 715124 | 0.020 |
Why?
|
| Macrophages | 1 | 2021 | 5805 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2017 | 2085 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2021 | 4118 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2011 | 1615 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2011 | 3825 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2011 | 3091 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 4091 | 0.010 |
Why?
|
| Liver | 1 | 2017 | 7647 | 0.010 |
Why?
|
| DNA Damage | 1 | 2011 | 2467 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 5098 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2011 | 3433 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2011 | 11192 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2011 | 10800 | 0.010 |
Why?
|
| Apoptosis | 1 | 2011 | 10112 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2017 | 23973 | 0.010 |
Why?
|
| Mice | 1 | 2011 | 80995 | 0.000 |
Why?
|
| Animals | 1 | 2011 | 170726 | 0.000 |
Why?
|